Cathera, Inc, the first Alembic portfolio company, developed the Phenom family of microcatheters optimized for intracranial navigation. Cathera was acquired by Medtronic in 2018. Palmera, Inc, a second Alembic portfolio company, is developing new therapeutic and novel products for the minimally invasive treatment of stroke that have the potential to improve outcome for patients that are currently treated, as well as widen the scope of patients that can benefit from therapy.
Looking for a particular Alembic, LLC employee's phone or email?
The Alembic, LLC annual revenue was $8.5 million in 2026.
Mike Fourkas is the VP Research and Development of Alembic, LLC.
14 people are employed at Alembic, LLC.
Alembic, LLC is based in Mountain View, California.
The NAICS codes for Alembic, LLC are [31, 312, 3121, 31214].
The SIC codes for Alembic, LLC are [20, 208].